newsfilter
← Latest News
Business Wire·

Sangamo Therapeutics Announces First Quarter 2025 Earnings Call

Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a genomic medicine company, today announced that the company has scheduled the release of its first quarter 2025 financial results after the markets close on Monday, May 12,